Pomalidomide combinations are a safe and effective option after daratumumab failure.
Brioli A, Gengenbach L, Mancuso K, Binder M, Ernst T, Heidel FH, Stauch T, Zamagni E, Hilgendorf I, Hochhaus A, Engelhardt M, von Lilienfeld-Toal M.
Brioli A, et al. Among authors: von lilienfeld toal m.
J Cancer Res Clin Oncol. 2023 Aug;149(9):6569-6574. doi: 10.1007/s00432-023-04637-x. Epub 2023 Feb 13.
J Cancer Res Clin Oncol. 2023.
PMID: 36781500
Free PMC article.